## **Core Concept**
The question describes a 9-year-old child with symptoms of fever, pain, and swelling in the mid-thigh, along with radiological features like a lamellated appearance and Codman's triangle. These findings are suggestive of a bone tumor, specifically Ewing's sarcoma, which is a type of small round cell tumor.
## **Why the Correct Answer is Right**
Ewing's sarcoma is a malignant bone tumor that commonly affects children and adolescents. The presence of fever, pain, and swelling in the mid-thigh, along with a lamellated appearance (onion-skin appearance due to layers of reactive bone) and Codman's triangle (a characteristic radiographic finding indicating periosteal reaction), are classic features of this condition. The tumor is positive for MIC2 (CD99), which is a specific marker for Ewing's sarcoma, helping in its diagnosis.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although osteosarcoma also presents with bone pain and swelling, the specific radiological features and the MIC2 positivity point more towards Ewing's sarcoma.
- **Option B:** This option is incorrect as it does not specifically relate to the details given in the scenario, which strongly suggest Ewing's sarcoma.
- **Option C:** This option might seem plausible but is incorrect because the details provided, especially the MIC2 positivity and the clinical presentation, are more characteristic of Ewing's sarcoma than other small round cell tumors like neuroblastoma or rhabdomyosarcoma.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Ewing's sarcoma often presents with systemic symptoms such as fever and weight loss, in addition to local symptoms. The MIC2 (CD99) positivity is a critical diagnostic marker, and the presence of a Codman's triangle and onion-skin periosteal reaction are classic radiographic findings.
## **Correct Answer:** . Ewing's Sarcoma
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.